Protagonist Therapeutics PTGX

$ 44.44 -4.43%

Annual report 2024
added 02-21-2025

Protagonist Therapeutics EV/EBITDA Ratio 2011-2025 | PTGX

Annual EV/EBITDA Ratio Protagonist Therapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-10.1	-10.7	-2.14	-2.36	-7.54	-3.13	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-2.14	-10.7	-6